| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
leucine zipper like transcription regulator 1 | 0.547 | 0.808 | 1.0E-92 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
nebulin | 0.608 | 0.692 | 4.6E-41 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FIG4 phosphoinositide 5-phosphatase | 0.551 | 0.731 | 2.3E-34 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
tetratricopeptide repeat domain 7A | 0.641 | 0.577 | 1.5E-31 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
tetratricopeptide repeat domain 37 | 0.626 | 0.654 | 1.7E-29 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
WD repeat domain 35 | 0.525 | 0.692 | 1.0E-22 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
chloride voltage-gated channel Kb | 0.593 | 0.692 | 1.4E-22 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
kinesin family member 7 | 0.528 | 0.731 | 2.3E-22 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
phosphatidylinositol glycan anchor biosynthesis class N | 0.558 | 0.615 | 2.3E-21 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
piezo type mechanosensitive ion channel component 1 | 0.552 | 0.769 | 3.9E-21 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
myosin heavy chain 3 | 0.563 | 0.654 | 6.7E-21 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
heparan sulfate proteoglycan 2 | 0.438 | 0.885 | 1.0E-19 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
cholinergic receptor nicotinic gamma subunit | 0.573 | 0.692 | 3.3E-19 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
integrin subunit beta 4 | 0.525 | 0.731 | 9.5E-19 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
phosphomannomutase 2 | 0.535 | 0.769 | 1.4E-17 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
Bardet-Biedl syndrome 9 | 0.615 | 0.577 | 4.2E-17 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
chloride voltage-gated channel Ka | 0.711 | 0.385 | 4.2E-17 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
integrin subunit alpha 7 | 0.588 | 0.654 | 4.3E-17 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
alanyl-tRNA synthetase 2, mitochondrial | 0.644 | 0.500 | 5.0E-17 |
|
phenotype | 0.100 | None | 0 | 2 | |||||||||||
|
solute carrier family 12 member 1 | 0.631 | 0.538 | 6.7E-17 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
beta 3-glucosyltransferase | 0.554 | 0.731 | 7.1E-17 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
KIAA0586 | 0.565 | 0.731 | 5.1E-16 |
|
phenotype | 0.100 | None | 0 | 0 |